Copertina

New Insights Into Pediatric Pulmonary Hypertension From Bogota: Is Younger Always Better?

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Michael A. Smith, Jeffrey R. Fineman
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Pulmonary Circulation
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Pulmonary Vascular Compromise Is Associated With Survival in Pediatric Pulmonary Hypertension: A New Computational Model
di: Maria Niccum, et al.
Pubblicazione: (2025)

How Is Pulmonary Hypertension Characterised and Treated in Children With Trisomy 21? Observations From the TOPP Registry (Tracking Outcomes and Practice in Pediatric Pulmonary Hypertension)
di: Tilman Humpl, et al.
Pubblicazione: (2025)

Physical Activity Traits From Wrist Sensors Correlate With Clinical Status in Pediatric Pulmonary Hypertension
di: Catherine M. Avitabile, et al.
Pubblicazione: (2026)

Beyond Resistance: Pulmonary Vascular Compromise as a Mechanistic Window Into Pediatric Pulmonary Hypertension
di: Megan Griffiths
Pubblicazione: (2025)

A Joint Perspective on End‐of‐Life Care in Pediatric Pulmonary Hypertension
di: Rebecca Kameny, et al.
Pubblicazione: (2025)

The Burden of Prior Authorizations for Pediatric Pulmonary Hypertension Medications: A Quantitative Assessment
di: Delphine Yung, et al.
Pubblicazione: (2025)

Pediatric Pulmonary Hypertension is Associated With Increased Circulating Levels of BMP 7 and CHIP
di: Edward C. Kirkpatrick, et al.
Pubblicazione: (2025)

Heart Rate Variability in Pulmonary Arterial Hypertension
di: Bishal Gyawali, et al.
Pubblicazione: (2025)

Balancing Risk and Hope: Insights Into Pregnancy Outcomes in Pulmonary Arterial Hypertension
di: Teresa Segura de la Cal, et al.
Pubblicazione: (2026)

Association of Antidiabetic Medication Classes With Survival Outcomes in Pulmonary Hypertension Patients With Diabetes
di: Aaron W. Trammell, et al.
Pubblicazione: (2026)

Prevalence and Economic Burden of Pulmonary Hypertension and Pulmonary Arterial Hypertension Among the Medicaid Population
di: Marshaleen Henriques King, et al.
Pubblicazione: (2025)

The Pulmonary Hypertension Global Patient Survey: Understanding the Invisible Burden of Paediatric Pulmonary Hypertension
di: Sadia Quyam, et al.
Pubblicazione: (2026)

My Introduction to Pulmonary Hypertension
di: Harrison W. Farber
Pubblicazione: (2025)

Reply To: “Pulmonary Artery Dilatation in Different Causes of Pulmonary Hypertension”
di: Caputo Annalisa, et al.
Pubblicazione: (2025)

Programmatic Approach to Outpatient Cardiac Catheterization in Children With Stable Pulmonary Arterial Hypertension
di: Gregory T. Adamson, et al.
Pubblicazione: (2025)

The Discovery of Inhaled Prostanoids for Pulmonary Hypertension
di: Werner Seeger
Pubblicazione: (2025)

Pulmonary Hypertension: A Personal Journey
di: Lewis J. Rubin
Pubblicazione: (2025)

Prognosis and Treatment With Phosphodiesterase 5 Inhibitors in Combined Post‐ and Precapillary Pulmonary Hypertension: A Propensity Score‐Matched Analysis From the Hellenic Pulmonary Hypertension Registry
di: Georgios E. Papadopoulos, et al.
Pubblicazione: (2025)

Hank the Heart and Animation‐Based Education for Pulmonary Hypertension
di: Michelle Cash, et al.
Pubblicazione: (2025)

Scimitar Syndrome and Pulmonary Hypertension in Pediatric Population: A Retrospective Analysis of the Prevalence, Clinical Characteristics, Risk Factors, and Outcomes
di: Abdullah Alkhani, et al.
Pubblicazione: (2026)

Characteristics of Daily Walking Bouts as Valid and Reliable Indicators of Exercise Capacity in Pulmonary Arterial Hypertension: Insights From the Randomized Controlled Study With Selexipag (TRACE)
di: Rana Zia Ur Rehman, et al.
Pubblicazione: (2025)

Melatonin in Pulmonary Arterial Hypertension: A Promising Adjunctive Therapy
di: Shaher Yar, et al.
Pubblicazione: (2025)

Prognostic Role of Platelets in Pulmonary Arterial Hypertension
di: Caio Julio Cesar dos Santos Fernandes, et al.
Pubblicazione: (2025)

Supplemental Oxygen Decreases Cardiac Effort in Pulmonary Arterial Hypertension
di: Kyle Norton, et al.
Pubblicazione: (2026)

American Lung Association Pulmonary Hypertension Roundtable: Executive Summary
di: Nicholas Andreas Kolaitis, et al.
Pubblicazione: (2025)

Sotatercept in Pulmonary Langerhans Cell Histiocytosis‐Associated Pulmonary Hypertension: A Case Series and Systematic Review
di: Giorgi Chilingarashvili, et al.
Pubblicazione: (2026)

Sotatercept to Wean Off Prostacyclin Infusion Therapy for Pulmonary Arterial Hypertension: A Case Report
di: Daniel J. Strick, et al.
Pubblicazione: (2025)

Treprostinil Is Associated With Early and Sustained Improvement in Group 3 Pulmonary Hypertension and Right Ventricular Function in Children
di: Kaushik Parvathaneni, et al.
Pubblicazione: (2026)

Role of a New Walk Test in Pulmonary Arterial Hypertension: A Retrospective Cohort Study
di: Junhao Jin, et al.
Pubblicazione: (2025)

The Role of Ion Channels in Pulmonary Hypertension: A Review
di: Han‐Fei Li, et al.
Pubblicazione: (2025)

Northern Pulmonary Hypertension: Personal Experience and Brief History
di: Andrey L. Chernyaev
Pubblicazione: (2025)

Reassessment of the Current Iron Deficiency Definition in Pulmonary Hypertension
di: Aurelia E. Reiser, et al.
Pubblicazione: (2025)

Early Results of Sotatercept Treatment in Patients With Severe Pulmonary Hypertension and a Potts Shunt
di: Manish A. Aggarwal, et al.
Pubblicazione: (2026)

How a Most Unlikely Drug Changed the Outcome of Pulmonary Arterial Hypertension
di: Ivan M. Robbins, et al.
Pubblicazione: (2025)

The Heterogeneity of Pulmonary Hypertension Nomenclature in Empiric Research Studies: Systematic Findings From Three Western European Countries
di: Armella Santi, et al.
Pubblicazione: (2025)

Transitioning From Parenteral Prostanoids to Oral Selexipag in Pulmonary Arterial Hypertension: A Multicenter Retrospective Cohort Study
di: Brandon Budhram, et al.
Pubblicazione: (2025)

Revised Precapillary Pulmonary Hypertension Criteria and Their Prognostic Value in IPF Transplant Waitlist Survival
di: Zehra Dhanani, et al.
Pubblicazione: (2025)

Pulmonary Arterial Wedge Oxygen Saturation: Does It Confirm Wedge Position in Patients With Pulmonary Hypertension?
di: Ambalavanan Arunachalam, et al.
Pubblicazione: (2025)

Chronic Obstructive Pulmonary Disease and Pulmonary Hypertension: A Comparative Study of Biomarkers and Clinical Indicators
di: Yingjun Huang, et al.
Pubblicazione: (2026)

The Interplay Between IL‐6, Hepcidin, and BMPR2 Signalling in Pulmonary Arterial Hypertension: Mechanistic Insights Into Vascular Remodelling
di: Quezia K. Toe, et al.
Pubblicazione: (2026)